Glucose Metabolic Reprogramming in Thyroid Cancer: Underlying Molecular Mechanisms and Links to Progression and Treatment

2026/05/13 by Yi-meng Zhang, Xin-yu Zeng, Yuan Wang +7 · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · #Adrenal and Paraganglionic Tumors #Cancer, Hypoxia, and Metabolism #Thyroid Cancer Diagnosis and Treatment

paper · doi:10.1007/s11596-026-00206-8

crossref issued 2026/05/13 · crossref published 2026/05/13 · crossref published-online 2026/05/13 · openalex publication_date 2026/05/13 · crossref created 2026/05/13 · openalex created_date 2026/05/14 · crossref published-print 2026/06/01 · crossref deposited 2026/06/29 · crossref indexed 2026/06/29 · openalex updated_date 2026/07/29

Citations

• �ber den Stoffwechsel der Carcinomzelle
• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
• Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies

Discussions

• #Thyroidcancer rewires glucose #metabolism & MAPK/PI3K signaling & upregulates glycolytic regulators. This review highlights therapeutic strategies & biomarker-driven stratification. See: doi.org/10. [bsky, 0 points, 0 comments]